Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmoteplase in Acute Ischemic Stroke (DIAS-4)
NCT00856661Phase 3Terminated
- Sponsor
- Lundbeck
- Start
- Apr 2009
- Primary completion
- Oct 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 14
01
Overview
Phase 3, randomised, double-blind trial in ischemic stroke comparing Desmoteplase with Placebo (2 arms). Primary endpoint: Modified Rankin Scale at Day 90. Started Apr 2009; status: terminated.
02
Drugs
desmoteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00856661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00856661.